BIIB

STRONG BUY

Biogen Inc.

Health Care

0.26

PEGY ratio

Rank #84

Why This Matters

This stock appears significantly undervalued relative to its growth and dividend yield. Strong projected growth of 82.1% annually over 5 years.

BIIB is trading at 21.0x earnings against 82.1% growth (no dividend), giving a PEGY of 0.26. The math suggests the stock is significantly undervalued relative to its growth and income profile.

~ Growth estimate uses historical CAGR (forward estimates unavailable)

• Growth rate derived from historical CAGR — limited analyst coverage.

Scan date: 2026-04-24

Valuation

21.0x

P/E Ratio

Growth

82.1%

5yr EPS

Income

0.0%

Div Yield

PEGY Components

PEGY Score0.26

Denominator82.1%

EPS (TTM)$8.79

Market Data

Price$184.38

ExchangeNASDAQ

S&P 500Nasdaq 100

What Changed

PEGY Score

0.25→0.26(+0.01)

Rank

#55→#84(29 positions)

vs 7 days ago

Portfolio Context

Founder does not hold this stock.

Not in your portfolio.

Sector: Health Care

PEGY History — 90 days

I Want to Invest Not Right Now

Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only